Acute Leukemia News

  • AACR 2019 Gilteritinib: 'Paradigm Shift' to Treat FLT3-Mutated AML The final readout of ADMIRAL shows significantly improved survival and remission rates with gilteritinib vs standard chemotherapy in relapsed/refractory FLT3-mutated AML, ushering in a new standard of care.
  • BSH 2019 Genome Sequencing Shows Clinical Promise in AML and ALL Whole genome sequencing could soon be used clinically to better characterise tumour profiles in leukaemia patients, potentially improving genomic stratification and therapy choices, say UK scientists.
 

Acute Leukemia Perspective

  • BSH 2019 Read clinically focused news coverage of key developments from BSH 2019
  • EBMT 2019 Read clinically focused news coverage of key developments from EBMT 2019
 

Acute Leukemia Journal Articles

 
here

http://steroid-pharm.com